The goal of this study is to measure bacterial burden, specifically Staph aureus, and how it spreads between mothers and their infants. Researchers will evaluate if the amount of bacteria on their skin remains the same after mothers use a skin antisepsis treatment prior to delivering their infants. The investigators also aim to assess participant interest in and compliance with skin antisepsis treatments. The hypothesis is that increased maternal interest will align with increased treatment compliance.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Staph aureus burden within maternal-infant dyads after exposure to a decolonization regimen
Timeframe: 12 months
Staph aureus epidemiology within maternal-infant dyads after exposure to a decolonization regimen
Timeframe: 12 months
Participant interest in skin decolonization
Timeframe: 12 months
Participant compliance with skin decolonization
Timeframe: 12 months